Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

How employers and plan sponsors can save the U.S. workforce from opioids

A. Bartley Bryt, MD, MPH
Policy
July 14, 2018
Share
Tweet
Share

Opioid use has reached epidemic proportions over the past decade, becoming one of America’s highest-priority public health issues. With opioid abuse spiraling out of control, lawmakers, regulators, and health professionals are scrambling to better understand key drivers of this issue and develop an effective action plan. Although the devastating impact of opioids on families and communities is well known, less focus has been given to how it affects the workplace and the role that employers and health care plan sponsors can play in combating it.

Opioids’ impact on America’s workforce

Opioid use is surging across the country, leading to an increasing number of drug-related deaths. This is largely an American problem, as America consumes 75 percent of the world’s opioids supply yet makes up just five percent of the world’s population. Of the 64,000 deaths from overdose in 2016, two-thirds were related to opioid overdoses. The oversupply and abuse of legal prescription pain relievers is at the heart of this crisis.

There is a misconception that opioid-related deaths occur disproportionately among youth. However, opioid misuse and related deaths occur most frequently within the working age population — those between 25 and 54 — meaning many people are using opioids while on the job. From a safety and work-quality point of view, opioid misuse is a significant challenge to both America’s workforce and to employers at large.

Another challenge is that of cost. Overuse of opioids contributes to health care costs of $8,600 per year on average in health care spending per person. This additional cost is severely burdening employers and plan sponsors, both of whom already pay annual premiums of $18,764 for employer-sponsored family health coverage, with workers on average paying $5,714 in 2017.

Employers and plan sponsors are already positioned to help

The power of employers and plan sponsors to address this crisis lies in the fact that most opioid addictions stem from medical prescriptions for pain relief. Plan sponsors have access to the pharmacy and medical care data of all members — meaning they can see who is using pain medication, such as opioids. Employers are also well positioned to identify potential opioid abuse, with side effects often noticeable in the workplace, such as reduced clarity and poor judgment, as well as changes in work product, behavior, and personal appearance.

With this widely unknown power in their hands, plan sponsors and employers must go above and beyond to not only educate themselves on opioids and the signs of abuse, but also to act on them.

What employers and plan sponsors can do

Beyond becoming better informed, a crucial step employers must take in order to address the opioid crisis is to create a company culture where individuals feel comfortable seeking help. One important tactic for achieving this is implementing new or enhancing existing employee assistance programs, which enable individuals to privately access help for a variety of personal concerns. From there, more targeted programs, such as ones that provide oversight and drug management, can help in providing support to employees using and abusing opioids.

An effective opioid oversight program needs to be tailored to the needs of both new opioid users and those who have been on long-term opioid treatment for pain management. For new users, the program should be centered on early intervention that helps avoid addiction, while for long-term users, it should focus on providing a structured support system to help individuals manage the conditions leading to opioid use and misuse. A good opioid oversight program, however, goes beyond just providing support — it also works with employers and contracted pharmacies to flag when an employee fills multiple opioid prescriptions written by different doctors, implements a medical review process before enabling refills, and monitors prescriptions and dosages to help support physician-directed intervention programs.

The opioid crisis affects individuals nationwide, people like you and me, tearing families apart, upending communities and compromising our current and future workforce. Employers and plan sponsors are uniquely positioned to play a key role in addressing this epidemic. By educating themselves, utilizing resources they already possess and taking action to maintain a safe working environment, employers and plan sponsors have the potential to be the unlikely heroes in ending the opioid epidemic, and — most importantly — in saving lives.

A. Bartley Bryt is chief medical officer, Brighton Health Plan Solutions.

ADVERTISEMENT

Image credit: Shutterstock.com

Prev

Female physicians: You’re lucky to be here

July 14, 2018 Kevin 34
…
Next

Why do so few doctors treat people with opioid addictions?

July 15, 2018 Kevin 8
…

Tagged as: Pain Management, Public Health & Policy

Post navigation

< Previous Post
Female physicians: You’re lucky to be here
Next Post >
Why do so few doctors treat people with opioid addictions?

ADVERTISEMENT

More by A. Bartley Bryt, MD, MPH

  • A strong doctor-patient relationship: why it matters

    A. Bartley Bryt, MD, MPH

Related Posts

  • The hidden benefits of your health insurance plan can save your life

    Michael L. Millenson
  • Physicians are being murdered for not prescribing opioids

    Jessica Jameson, MD
  • Blame the pain, not the opioids

    Angelika Byczkowski
  • What does Kelly Loeffler’s health plan do to coverage for preexisting conditions?

    Robert Laszewski
  • Open enrollment: It’s time to leave your insurance plan behind

    Andy Schoonover
  • Patients in Sweden received fewer post-op opioids. Why is that?

    Richard Young, MD

More in Policy

  • Online eye exams spark legal battle over health care access

    Joshua Windham, JD and Daryl James
  • The One Big Beautiful Bill and the fragile heart of rural health care

    Holland Haynie, MD
  • Why health care leaders fail at execution—and how to fix it

    Dave Cummings, RN
  • Healing the doctor-patient relationship by attacking administrative inefficiencies

    Allen Fredrickson
  • The hidden health risks in the One Big Beautiful Bill Act

    Trevor Lyford, MPH
  • The CDC’s restructuring: Where is the voice of health care in the room?

    Tarek Khrisat, MD
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Beyond burnout: Understanding the triangle of exhaustion [PODCAST]

      The Podcast by KevinMD | Podcast
    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Beyond burnout: Understanding the triangle of exhaustion [PODCAST]

      The Podcast by KevinMD | Podcast
    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

How employers and plan sponsors can save the U.S. workforce from opioids
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...